(Q57217515)

English

Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder

article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Further evidence of the involvement of alpha-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

based on heuristic

inferred from title

Luis Augusto Rohde

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Roman T

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Polanczyk GV

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Zeni C

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Genro JP

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Molecular Psychiatry

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

8-10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001743

0 references

The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function. Potential significance for attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Attention-deficit/hyperactivity disorder (ADHD) as a noradrenergic disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Attention-deficit/hyperactivity disorder: advancing on pharmacogenomics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Genetic polymorphisms, lipoproteins and coronary artery disease risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

21 January 2018

Linkage study of the α2A adrenergic receptor in attention-deficit hyperactivity disorder families

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001743

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.MP.4001743

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16172611%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57217515&oldid=1466151519"